Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer

Author： Liu Bin   Conrad Fraser   Roth Audrey   Drummond Daryl   Simko Jeff   Marks James  

Publisher： Springer Publishing Company

ISSN： 0946-2716

Source： Journal of Molecular Medicine, Vol.85, Iss.10, 2007-10, pp. : 1113-1123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

TREATMENT WITH PREDNISOLONE OF HORMONE-REFRACTORY PROSTATE CANCER

By Fuse H.   Nozaki T.   Fujiuchi Y.   Mizuno I.   Nagakawa O.   Okumura A.  

Archives of Andrology, Vol. 52, Iss. 1, 2006-01 ,pp. : 35-38

Informa Healthcare

Access to resources Recommend Favorite

Role of Chemotherapy in Hormone-Refractory Prostate Cancer

By  

Urologia Internationalis, Vol. 70, Iss. 1, 2003-02 ,pp. : 1-14

Karger

Access to resources Recommend Favorite

REDISTRIBUTION OF ANDROGEN RECEPTORS IN ACQUIRED HORMONE-REFRACTORY PROSTATE CANCER CELLS

By Yu D. S.   Hsieh D. S.   Chang S. Y.  

Archives of Andrology, Vol. 52, Iss. 5, 2006-09 ,pp. : 389-395

Informa Healthcare

Access to resources Recommend Favorite

A Weekly Schedule of Docetaxel for Metastatic Hormone-Refractory Prostate Cancer

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 281-287

Karger

Access to resources Recommend Favorite

Hormonal Sensitivity following Endocrine Withdrawal in Hormone-Refractory Prostate Cancer

By  

Urologia Internationalis, Vol. 65, Iss. 1, 2000-08 ,pp. : 28-31

Karger

Access to resources Recommend Favorite